Alpha DNA Investment Management’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-243
Closed -$52K 785
2020
Q4
$52K Buy
+243
New +$49.7K 0.06% 179

Other funds holding VRSN

Alpha DNA Investment Management's VRSN Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of VeriSign (VRSN) in Q1 2021, closing a stake of 243 shares — an estimated $52K sold.

Alpha DNA Investment Management first reported a position in VRSN in Q4 2020 and held it in 1 quarter. The position peaked at $52K in Q4 2020. 543 funds tracked by Wall St. Rank hold VRSN as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining VeriSign position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 243 VeriSign shares in Q1 2021, an estimated $52K.
  • Alpha DNA Investment Management first reported a position in VeriSign in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's VeriSign position peaked at $52K in Q4 2020.
  • 543 funds tracked by Wall St. Rank held VeriSign as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.